Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02835859 · ClinicalTrials.gov registry record · NA

Intestinal Sweet Taste Receptor Function and Adaptation to Dietary Sugars and Sweeteners

A NA study of Diabetes, sponsored by AdventHealth Translational Research Institute.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT02835859 is a NA study of Diabetes that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 10 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02835859, a NA study of Diabetes, has completed, sponsored by AdventHealth Translational Research Institute.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect data that will help researchers better understand the various causes of obesity and diabetes; particularly to understand how consumption of NCASs affects the way the body uses nutrients.

Conditions Studied

Interventions

  • OTHER Dietary: saccharin
  • OTHER Estimate glucose absorptions

Study Locations (1)

Florida

  • Translational Research Institute for Metabolism and Diabetes - Orlando

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-08
Est. Completion 2017-09
Phase NA

What the Registry Record Tells You About NCT02835859

The ClinicalTrials.gov registry entry for NCT02835859 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Dietary: saccharin is the first listed.

NCT02835859 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02835859 about?

NCT02835859 is a clinical study titled "Intestinal Sweet Taste Receptor Function and Adaptation to Dietary Sugars and Sweeteners". The purpose of this study is to collect data that will help researchers better understand the various causes of obesity and diabetes; particularly to understand how consumption of NCASs affects the way the body uses nutrients.

What is the current status of trial NCT02835859?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-08. Estimated completion is 2017-09.

What conditions does trial NCT02835859 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT02835859?

The interventions under investigation include: Dietary: saccharin (OTHER), Estimate glucose absorptions (OTHER).

Who is sponsoring clinical trial NCT02835859?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02835859 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.